File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/s12889-024-18811-4
- Scopus: eid_2-s2.0-85193464917
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Association between sleep patterns and galectin-3 in a Chinese community population
Title | Association between sleep patterns and galectin-3 in a Chinese community population |
---|---|
Authors | |
Keywords | Galectin-3 Inflammation Napping duration Sleep disturbance Sleep duration |
Issue Date | 16-May-2024 |
Publisher | BioMed Central |
Citation | BMC Public Health, 2024, v. 24, n. 1 How to Cite? |
Abstract | BackgroundIrregular sleep patterns have been associated with inflammation. Galectin-3, a novel biomarker, plays an important role in inflammation. We investigated the relationship between sleep patterns and galectin-3 in a Chinese population. MethodsA total of 1,058 participants from the Shenzhen-Hong Kong United Network on Cardiovascular Disease study were included in the analysis. Age and sex-adjusted linear regression models were employed to investigate the relationship between galectin-3 level and traditional metabolic biomarkers. Logistic regression models were used to estimate the association among sleep disturbance, nighttime sleep duration, and daytime napping duration and elevated galectin-3, with elevated galectin-3 defined as galectin-3 level > 65.1 ng/ml. ResultsOf study participants, the mean age was 45.3 years and 54.3% were women. Waist circumference, natural logarithm (ln)-transformed triglyceride, and ln-transformed high sensitivity C-reactive protein were positively associated with galectin-3 level (age and sex-adjusted standardized β [95% confidence interval (CI)], 0.12 [0.04, 0.21], 0.11 [0.05, 0.17], and 0.08 [0.02, 0.14], respectively). Sleep disturbance was associated with elevated galectin-3 (odds ratio [95% CI], 1.68 [1.05, 2.68], compared to those without sleep disturbance) after adjusting for traditional metabolic biomarkers. No interaction was observed between galectin-3 and age, sex, obesity, hypertension, and diabetes on sleep disturbance. No association was found between nighttime sleep duration or daytime napping duration and elevated galectin-3. ConclusionsOur study provides evidence of a significant association between sleep disturbance and elevated galectin-3 level, independent of traditional metabolic biomarkers. Screening and interventions on galectin-3 could assist in preventing sleep disturbance-induced inflammatory disease. |
Persistent Identifier | http://hdl.handle.net/10722/348683 |
ISSN | 2023 Impact Factor: 3.5 2023 SCImago Journal Rankings: 1.253 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, Lin | - |
dc.contributor.author | Zhen, Juanying | - |
dc.contributor.author | Liu, Shuyun | - |
dc.contributor.author | Ren, Lijie | - |
dc.contributor.author | Zhao, Guoru | - |
dc.contributor.author | Liang, Jianguo | - |
dc.contributor.author | Xu, Aimin | - |
dc.contributor.author | Li, Chao | - |
dc.contributor.author | Wu, Jun | - |
dc.contributor.author | Cheung, Bernard Man Yung | - |
dc.date.accessioned | 2024-10-11T00:31:29Z | - |
dc.date.available | 2024-10-11T00:31:29Z | - |
dc.date.issued | 2024-05-16 | - |
dc.identifier.citation | BMC Public Health, 2024, v. 24, n. 1 | - |
dc.identifier.issn | 1471-2458 | - |
dc.identifier.uri | http://hdl.handle.net/10722/348683 | - |
dc.description.abstract | <h3>Background</h3><p>Irregular sleep patterns have been associated with inflammation. Galectin-3, a novel biomarker, plays an important role in inflammation. We investigated the relationship between sleep patterns and galectin-3 in a Chinese population.</p><h3>Methods</h3><p>A total of 1,058 participants from the Shenzhen-Hong Kong United Network on Cardiovascular Disease study were included in the analysis. Age and sex-adjusted linear regression models were employed to investigate the relationship between galectin-3 level and traditional metabolic biomarkers. Logistic regression models were used to estimate the association among sleep disturbance, nighttime sleep duration, and daytime napping duration and elevated galectin-3, with elevated galectin-3 defined as galectin-3 level > 65.1 ng/ml.</p><h3>Results</h3><p>Of study participants, the mean age was 45.3 years and 54.3% were women. Waist circumference, natural logarithm (ln)-transformed triglyceride, and ln-transformed high sensitivity C-reactive protein were positively associated with galectin-3 level (age and sex-adjusted standardized β [95% confidence interval (CI)], 0.12 [0.04, 0.21], 0.11 [0.05, 0.17], and 0.08 [0.02, 0.14], respectively). Sleep disturbance was associated with elevated galectin-3 (odds ratio [95% CI], 1.68 [1.05, 2.68], compared to those without sleep disturbance) after adjusting for traditional metabolic biomarkers. No interaction was observed between galectin-3 and age, sex, obesity, hypertension, and diabetes on sleep disturbance. No association was found between nighttime sleep duration or daytime napping duration and elevated galectin-3.</p><h3>Conclusions</h3><p>Our study provides evidence of a significant association between sleep disturbance and elevated galectin-3 level, independent of traditional metabolic biomarkers. Screening and interventions on galectin-3 could assist in preventing sleep disturbance-induced inflammatory disease.</p> | - |
dc.language | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.ispartof | BMC Public Health | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Galectin-3 | - |
dc.subject | Inflammation | - |
dc.subject | Napping duration | - |
dc.subject | Sleep disturbance | - |
dc.subject | Sleep duration | - |
dc.title | Association between sleep patterns and galectin-3 in a Chinese community population | - |
dc.type | Article | - |
dc.identifier.doi | 10.1186/s12889-024-18811-4 | - |
dc.identifier.scopus | eid_2-s2.0-85193464917 | - |
dc.identifier.volume | 24 | - |
dc.identifier.issue | 1 | - |
dc.identifier.eissn | 1471-2458 | - |
dc.identifier.issnl | 1471-2458 | - |